# Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder

Canonical: https://abierto.us/opportunities/noipcanida09054

- Solicitation number: NOI-PCA-NIDA-09054
- Notice type: Special notice
- Status: Closed. Deadline was September 15, 2026 at 3:00 PM EDT
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health (n-NATIONALINSTITUTESOFHEALTH)
- NAICS: 541380 Testing Laboratories and Services
- Product or service code: Q301 Reference Laboratory Testing
- Place of performance: Baltimore, Maryland
- First posted: September 8, 2026
- Last posted: September 8, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/c0fa055913f647c4b3262722fd66122f/view

## Description

Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work.

## Publications

- September 8, 2026: Special notice, due September 15, 2026 at 3:00 PM EDT. Notice c0fa055913f647c4b3262722fd66122f. https://sam.gov/workspace/contract/opp/c0fa055913f647c4b3262722fd66122f/view

## Points of contact

- Zachary Fetters, zachary.fetters@nih.gov, 2402369291
- Ashley Kinderdine, ashley.kinderdine@nih.gov, 2406695154

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/noipcanida09054.